West Pharmaceutical Services Inc (NYSE:WST)
| 367.76 BATS BZX Real-Time Price As of 2:16pm ET |  -7.45 / -1.99%Today’s Change | 206.19 Today|||52-Week Range 415.73 | +56.26% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 95.6M | 143.6M | 150.7M | 206.9M | |
| Depreciation | 89.9M | 90.7M | 96.7M | 104.4M | ||
| Total Other Cash Flow | 46.6M | 22.3M | 15.6M | 4.7M | ||
| Funds From Operations | 223.2M | 278.1M | 304.7M | 316.9M | ||
| Funds From/For Other Operating Expenses | 10.8M | 58.7M | 41.4M | 28.3M | ||
| Net Cash Flow - Operating Activities | 212.4M | 219.4M | 263.3M | 288.6M | ||
| Investing | Increase In Investments | 0.00 | -8.4M | 0.00 | 0.00 | |
| Capital Expenditures | -131.6M | -170.2M | -130.8M | -104.7M | ||
| Other Investing - Uses | 0.00 | 0.00 | -6.0M | 0.00 | ||
| Other Investing - Sources | 2.1M | 2.8M | 3.2M | 3.9M | ||
| Net Cash Flow Investing | -129.5M | -175.8M | -133.6M | -100.8M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 70.4M | 0.00 | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -98.8M | -69.8M | -34.9M | -100.0K | ||
| Net Proceeds Stock Sale | 12.7M | 25.9M | 39.5M | 31.8M | ||
| Common Preferred Redeemed | -5.6M | -55.9M | -78.2M | -75.2M | ||
| Common Dividends | -32.4M | -35.8M | -39.1M | -42.1M | ||
| Cash Dividends Paid - Total | -32.4M | -35.8M | -39.1M | -42.1M | ||
| Other Sources - Financing | 12.3M | 22.0M | 4.4M | 4.9M | ||
| Other Uses - Financing | 100.0K | 300.0K | 700.0K | 0.00 | ||
| Net Cash Flow - Financing | -41.5M | -113.9M | -109.0M | -80.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -22.1M | -1.3M | 12.2M | -5.6M | |
| Net Change In Cash | 41.4M | -70.3M | 20.7M | 107.1M | ||
